The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men

Stroke

Volumn 40, Issue 2, 2009, Pages 344-349

  Arenillas, Juan F ^a,c   Sandoval, Patricio ^a   De La Ossa, Natalia Pérez ^a   Millán, Mónica ^a   Guerrero, Cristina ^a   Escudero, Domingo ^a   Dorado, Laura ^a   López Cancio, Elena ^a   Castillo, Jose ^b   Dávalos, Antoni ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Acute stroke; Metabolic syndrome; Outcome; Sex differences; Thrombolysis

Indexed keywords

ANTITHROMBOCYTIC AGENT; CITICOLINE; DISUFENTON SODIUM; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT RESPONSE; ACUTE DISEASE; BRAIN ISCHEMIA; DRUG RESISTANCE; MIDDLE CEREBRAL ARTERY; PATHOLOGY; RISK; SEXUAL DEVELOPMENT; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; DRUG RESISTANCE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY; ODDS RATIO; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; SEX CHARACTERISTICS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 60549115022     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.531079     Document Type: Article

References (27)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F;American Heart Association;National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
2. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk In Communities study. Diabetes Care. 2005;28:385-390.
3. Malik S, Wong ND, Franklin SS, Kamath TV, LTtalien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-1250.
4. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care. 2005;28:2745-2749.
5. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, Ditullio MR, Homma S, Paik MC. Metabolic syndrome and ischemic stroke risk:Northern Manhattan Study. Stroke. 2008;39:30-35.
6. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S;Study of Health Assessment and Risk in Ethnic Groups. Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation. 2003;108:420-425.
7. Arenillas JF, Moro MA, Davalos A. The metabolic syndrome and stroke:potential treatment approaches. Stroke. 2007;38:2196-2203.
8. Arenillas JF, Ispierto L, Millán M, Escudero D, Pérez de la Ossa N, Dorado L, Guerrero C, Serena J, Castillo J, Dávalos A. Metabolic syndrome and resistance to iv thrombolysis in middle cerebral artery ischemic stroke. Neurology. 2008;71:190-195.
9. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke. 2005;36:1212-1217.
10. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G. SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST):an observational study. Lancet. 2007;369:275-282.
11. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke:definitions for use in a multicenter clinical trial:TOAST:Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
12. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke. 2001;32:89-93.
13. Reaven G. Metabolic syndrome:pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286-288.
14. Bouser MG. Stroke in women. Circulation. 1999;99:463-467.
15. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke. 2003;34:1581-1585.
16. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke:a pooled analysis of randomized clinical trials. Stroke. 2005;36:62-65.
17. Elkind MSV, Praabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology. 2007;68:842-848.
18. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005;36:1447-1451.
19. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study:a randomized controlled trial:Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
20. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabín J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke. 2004;35:486-490.
21. Murphy MJ, Metcalf BS, Voss LD, Jeffery AN, Kirkby J, Mallam KM, Wilkin TJ. Girls at five are intrinsically more insulin resistant than boys:the Programming Hypotheses Revisited-The Early Bird Study (Early Bird 6). Pediatrics. 2004;113:82-86.
22. Mansfield MW, Heywood DM, Grant PJ. Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16:160-164.
23. Ossei-Gerning N, Wilson IJ, Grant PJ. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb Haemost. 1998;79:736-740.
24. Donahue RP, Rejman K, Rafalson LB, Dmochowski J, Stranges S, Trevisan M. Sex differences in endothelial function markers before conversion to pre-diabetes:does the clock start ticking earlier among women?. Diabetes Care. 2007;30:354-359.
25. Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack:a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke. 2005;36:1366-1371.
26. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, Vaske D, Briley D, Briley L, Kopf J, McMillen P, Nguyen Q, Reisman M, Lai EH, Joslyn G, Shepherd NS, Bell C, Wagner MJ, Burns DK. American Diabetes Association GENNID Study Group. Genetics of NIDDM:genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet. 2000;66:1871-1881.
27. Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia. 2001;44:537-543.